Health Catalyst, Inc. (HCAT)

Health Catalyst Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	311.27	306.58	295.94	276.24	241.93	188.85
Revenue Growth (YoY)	4.88%	3.60%	7.13%	14.18%	28.11%	21.88%
Cost of Revenue	168.28	164.79	161.11	140.68	124.17	98.08
Gross Profit	143	141.79	134.83	135.56	117.76	90.77
Selling, General & Admin	96.54	100.65	111.06	144.37	132.32	96.5
Research & Development	55.93	56.8	68.5	69.23	61.83	53.52
Operating Expenses	195.69	198.89	221.78	261.89	231.68	168.74
Operating Income	-52.69	-57.1	-86.96	-126.33	-113.92	-77.97
Interest Expense	-22.57	-17.09	-7.29	-1.68	-	-11.57
Interest & Investment Income	17.62	17.98	16.39	-	-	-
Other Non Operating Income (Expenses)	-0.11	-0.26	0	-	-16.46	-
EBT Excluding Unusual Items	-57.75	-56.46	-77.85	-128.01	-130.38	-89.54
Merger & Restructuring Charges	-16.11	-12.15	-14.58	-13.32	-7.89	-2.67
Asset Writedown	-	-2.2	-4.08	-5.02	-1.8	-
Legal Settlements	-	-	-21.28	-	-	-
Other Unusual Items	1.64	1.64	-	4.67	-20.04	-24
Pretax Income	-72.22	-69.17	-117.79	-141.68	-160.11	-116.21
Income Tax Expense	0.44	0.33	0.36	-4.28	-6.9	-1.19
Earnings From Continuing Operations	-	-69.5	-118.15	-137.4	-153.21	-115.02
Net Income	-72.66	-69.5	-118.15	-137.4	-153.21	-115.02
Net Income to Common	-72.66	-69.5	-118.15	-137.4	-153.21	-115.02
Shares Outstanding (Basic)	63	60	56	54	47	40
Shares Outstanding (Diluted)	63	60	56	54	47	40
Shares Change (YoY)	9.58%	6.68%	4.32%	13.87%	20.12%	110.98%
EPS (Basic)	-1.16	-1.15	-2.09	-2.56	-3.23	-2.91
EPS (Diluted)	-1.16	-1.15	-2.09	-2.63	-3.23	-2.91
Free Cash Flow	2.5	12.94	-34.32	-37.44	-33.57	-33.92
Free Cash Flow Per Share	0.04	0.21	-0.61	-0.69	-0.71	-0.86
Gross Margin	45.94%	46.25%	45.56%	49.07%	48.68%	48.07%
Operating Margin	-16.93%	-18.62%	-29.38%	-45.73%	-47.09%	-41.29%
Profit Margin	-23.34%	-22.67%	-39.92%	-49.74%	-63.33%	-60.91%
Free Cash Flow Margin	0.80%	4.22%	-11.60%	-13.55%	-13.88%	-17.96%
EBITDA	-19.67	-25.37	-53.24	-84.83	-78.79	-59.94
EBITDA Margin	-6.32%	-8.27%	-17.99%	-30.71%	-32.57%	-31.74%
D&A For EBITDA	33.03	31.73	33.72	41.5	35.13	18.03
EBIT	-52.69	-57.1	-86.96	-126.33	-113.92	-77.97
EBIT Margin	-16.93%	-18.62%	-29.38%	-45.73%	-47.09%	-41.29%
Revenue as Reported	311.27	306.58	295.94	276.24	241.93	188.85
Advertising Expenses	-	5.1	2.6	5.7	4.4	4.3

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q